Visual Processing Speed and Objective Analysis of Ocular Movements in Multiple Sclerosis
Launched by INSTITUTO UNIVERSITARIO DE OFTALMOBIOLOGÍA APLICADA (INSTITUTE OF APPLIED OPHTHALMOBIOLOGY) - IOBA · Jan 20, 2023
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Anamnesis, ophthalmological medical history including difficulties in reading with appropriate glasses.
The following protocol will be applied:
* Comprehensive eye examination
* Stereopsis
* Primary gaze position
* Cover test: far and near
* Vergence and version eye movements
* Presence of nystagmus
* Far and near best corrected visual acuity, with updated refraction
-.Pupillary light reflex
* Biomicroscopy of the anterior pole
* Intraocular pressure
* Recording of eye movements during two standardized tests: International Reading Speed Texts test (IReST®) and Developmental Eye Movemen...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of Multiple Sclerosis
- • Best distant corrected visual acuity equal or greater than 0.7 (decimal scale). Glasses or soft contact lenses users.
- • Best close corrected visual acuity equal to or greater than 20/30 (Snellen scale).Glasses or soft contact lenses users.
- Exclusion Criteria:
- • Patients with a history of acute optic neuritis (ON) and/or who experienced an episode of ON \<6 months prior to the study, to avoid potential interference of papilledema with accurate peripapillary RNFL thickness measurements.
- • Patients with other retinal and optic nerve diseases, advanced cataracts according to the international Lens Opacities Classification System III (LOCS III) (opacities greater than C2N2)
- • Patients with other ophthalmological diseases that could affect central visual acuity
- • Subjects with high refractive error (+ - 6 diopters).
- • Subjects with other demyelinating disorders (neuromyelitis optica or acute disseminated encephalomyelitis).
About Instituto Universitario De Oftalmobiología Aplicada (Institute Of Applied Ophthalmobiology) Ioba
The Instituto Universitario de Oftalmobiología Aplicada (IOBA) is a leading research institution dedicated to advancing the field of ophthalmology through innovative clinical trials and applied research. Based at the intersection of academia and healthcare, IOBA focuses on developing cutting-edge therapies and diagnostic tools for ocular diseases, aiming to enhance patient outcomes and contribute to the global body of knowledge in vision science. With a team of expert researchers and clinicians, IOBA fosters collaboration and knowledge transfer, striving to translate scientific advancements into practical solutions for eye health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Valladolid, , Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials